-->
membre depuis:
Portefeuille démarré:
Dernière connexion:
26-12-19
26-12-19
13-07-20 07:18
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
13/07/20 | STMICROELECTRONICS NV | Achat | 8 000 E | 25.77 | 29.27 | 11.32% | 906 | 7 | |
13/07/20 | ATEME | Achat | 7 500 E | 13.46 | 16.80 | 22.54% | 1 691 | 7 | |
17/02/20 | CAPGEMINI SE | Achat | 5 500 E | 115.00 | 112.90 | -7.50% | -413 | 6 | |
17/02/20 | INGENICO | Achat | 3 500 E | 137.00 | 133.85 | -2.50% | -88 | 10 | |
31/01/20 | VINCI | Achat | 8 000 E | 100.45 | 75.14 | -31.24% | -2 499 | 5 | |
26/12/19 | EIFFAGE SA | Achat | 15 000 E | 102.25 | 72.62 | -35.86% | -5 379 | 9 | |
Enregistrements 1 à 6 sur 6 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
13/07/20 | EMEIS (EX ORPEA) | Achat | 5 000 E | 116.40 | 100.70 | -18.05% | -903 | 5 | |
28/04/20 | LECTRA | Achat | 5 000 E | 22.40 | 14.04 | -37.48% | -1 874 | 4 | |
30/03/20 | SODEXO | Achat | 7 500 E | 100.00 | 60.00 | -41.14% | -3 086 | 5 | |
30/03/20 | KERING | Achat | 10 000 E | 577.70 | 479.85 | -18.38% | -1 838 | 4 | |
04/02/20 | GROUPE CRIT | Achat | 3 500 E | 73.10 | 69.17 | -5.83% | -204 | 4 | |
03/02/20 | KERING | Achat | 12 000 E | 582.00 | 551.50 | -6.34% | -761 | 5 | |
31/01/20 | SODEXO | DIV | 0 E | 0.00 | 2.90 | 0.00% | 217 | 2 | |
31/01/20 | STMICROELECTRONICS NV | Achat | 4 500 E | 27.43 | 25.69 | -6.70% | -302 | 3 | |
31/01/20 | AB SCIENCE | Achat | 10 000 E | 8.15 | 7.78 | -4.74% | -474 | 3 | |
31/01/20 | SODEXO | Achat | 8 000 E | 106.70 | 94.98 | -11.99% | -959 | 5 | |
31/01/20 | AB SCIENCE | Achat | 5 500 E | 7.91 | 8.19 | 3.29% | 181 | 2 | |
29/01/20 | EQUASENS | Achat | 5 000 E | 65.20 | 60.00 | -8.28% | -414 | 4 | |
29/01/20 | GROUPE OPEN | Achat | 2 000 E | 13.02 | 12.34 | -5.42% | -108 | 3 | |
29/01/20 | VERALLIA | Achat | 3 500 E | 31.10 | 33.09 | 6.05% | 212 | 2 | |
29/01/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 4 000 E | 6.73 | 6.25 | -7.44% | -298 | 3 | |
29/01/20 | BIOMERIEUX | Achat | 4 000 E | 85.25 | 90.70 | 5.67% | 227 | 2 | |
29/01/20 | VERALLIA | Achat | 4 500 E | 30.68 | 32.80 | 6.26% | 282 | 5 | |
29/01/20 | STMICROELECTRONICS NV | Achat | 11 000 E | 25.36 | 27.36 | 7.47% | 822 | 2 | |
24/01/20 | CATANA GROUP | Achat | 8 000 E | 3.94 | 3.93 | -1.13% | -90 | 8 | |
24/01/20 | STMICROELECTRONICS NV | Achat | 5 000 E | 24.28 | 27.41 | 12.00% | 600 | 5 | |
23/01/20 | PIXIUM VISION | Achat | 2 000 E | 1.08 | 0.97 | -10.38% | -208 | 3 | |
15/01/20 | AMOEBA | Achat | 6 000 E | 0.59 | 0.66 | 11.61% | 697 | 9 | |
14/01/20 | KERING | DIV | 0 E | 0.00 | 3.50 | 0.00% | 72 | 1 | |
14/01/20 | PIXIUM VISION | Achat | 2 500 E | 1.02 | 1.18 | 15.47% | 387 | 3 | |
14/01/20 | ADOCIA | Achat | 9 000 E | 11.60 | 11.24 | -3.32% | -299 | 4 | |
10/01/20 | AURES TECHNOLOGIES | Achat | 3 000 E | 24.95 | 25.05 | 0.20% | 6 | 5 | |
10/01/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 5 000 E | 6.97 | 6.84 | -2.09% | -105 | 4 | |
10/01/20 | EOS IMAGING | Achat | 4 500 E | 2.75 | 2.62 | -4.97% | -224 | 4 | |
09/01/20 | ONCODESIGN (RETRAIT 12-22) | Achat | 2 000 E | 10.70 | 11.55 | 7.74% | 155 | 9 | |
09/01/20 | AMPLITUDE SURGICAL | Achat | 3 500 E | 1.69 | 1.72 | 1.57% | 55 | 5 | |
09/01/20 | EUROPACORP | Achat | 4 500 E | 0.98 | 0.90 | -8.38% | -377 | 3 | |
09/01/20 | AMOEBA | Achat | 6 000 E | 0.54 | 0.50 | -7.65% | -459 | 6 | |
08/01/20 | DEINOVE | Achat | 2 000 E | 0.89 | 0.96 | 7.66% | 153 | 4 | |
07/01/20 | MAUNA KEA TECHNOLOGIES | Achat | 4 000 E | 1.64 | 1.72 | 4.65% | 186 | 2 | |
07/01/20 | GENSIGHT BIOLOGICS SA | Achat | 2 500 E | 3.10 | 3.32 | 6.89% | 172 | 2 | |
06/01/20 | MAUNA KEA TECHNOLOGIES | Achat | 2 500 E | 1.64 | 1.70 | 3.45% | 86 | 1 | |
06/01/20 | NICOX SA | Achat | 3 500 E | 4.68 | 4.47 | -4.78% | -167 | 6 | |
06/01/20 | MAUNA KEA TECHNOLOGIES | Achat | 3 500 E | 1.50 | 1.81 | 20.38% | 713 | 5 | |
02/01/20 | MAUNA KEA TECHNOLOGIES | Achat | 3 500 E | 1.27 | 1.42 | 11.46% | 401 | 3 | |
30/11/-1 | ALBIOMA | Achat | 4 000 E | 28.85 | 45.75 | 52.87% | 2 115 | 7 | |
Enregistrements 1 à 40 sur 40 |